{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-066621","form_type":"8-K","ticker":"SRTS","cik":"0001494891","company_name":"Sensus Healthcare, Inc.","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.238216+00:00","generated_at":"2026-05-31T10:50:34.392500+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sensus Healthcare Q2 2024 revenue $9.2M (+104% YoY); net income $1.6M","bullets":["Revenue $9.2M vs $4.5M in Q2 2023, up 104%; 23 systems shipped (including 3 to Asia) vs 13 last year.","Net income $1.6M ($0.10 diluted EPS) vs net loss of $0.4M ($0.02 loss per share) in Q2 2023.","Adjusted EBITDA $2.1M vs negative $1.0M in prior-year quarter.","Signed 15 Fair Deal Agreements for SRT-100 Vision units since March 2024; recurring revenue expected in 2025.","Cash and equivalents $19.0M, no debt; accounts receivable $18.3M vs $10.6M at Dec 31, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-066621","json":"https://secwatch.observer/filing/0001213900-24-066621.json","markdown":"https://secwatch.observer/filing/0001213900-24-066621.md","text":"https://secwatch.observer/filing/0001213900-24-066621.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1494891/000121390024066621/0001213900-24-066621-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1494891/000121390024066621/ea0210736-8k_sensus.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:50:34.392500+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}